These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35708905)

  • 21. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
    Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
    Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
    Wang X; Chen Q
    BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated autocrine chemokine ligand 18 expression promotes oral cancer cell growth and invasion via Akt activation.
    Jiang X; Wang J; Chen X; Hong Y; Wu T; Chen X; Xia J; Cheng B
    Oncotarget; 2016 Mar; 7(13):16262-72. PubMed ID: 26919103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DKK1-CKAP4 signal axis promotes hepatocellular carcinoma aggressiveness.
    Iguchi K; Sada R; Matsumoto S; Kimura H; Zen Y; Akita M; Gon H; Fukumoto T; Kikuchi A
    Cancer Sci; 2023 May; 114(5):2063-2077. PubMed ID: 36718957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
    Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
    Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LRRC59 promotes the progression of oral squamous cell carcinoma by interacting with SRP pathway components and enhancing the secretion of CKAP4-containing exosomes.
    Sun Q; Jin L; Dong S; Zhang L
    Heliyon; 2024 Mar; 10(6):e28083. PubMed ID: 38533057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
    Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
    Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma.
    Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dickkopf-related protein 1/cytoskeleton-associated protein 4 signaling activation by
    Luo M; Chen YJ; Xie Y; Wang QR; Xiang YN; Long NY; Yang WX; Zhao Y; Zhou JJ
    World J Gastroenterol; 2022 Dec; 28(47):6769-6787. PubMed ID: 36620343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic palmitoylation controls the microdomain localization of the DKK1 receptors CKAP4 and LRP6.
    Sada R; Kimura H; Fukata Y; Fukata M; Yamamoto H; Kikuchi A
    Sci Signal; 2019 Nov; 12(608):. PubMed ID: 31744930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
    Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E
    BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
    Qu Y; He Y; Ruan H; Qin L; Han Z
    Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of Tyrosine Kinase Receptor 2 in Oral Squamous Cell Carcinoma and the Effect on Cell Proliferation and Migration and Epithelial-Mesenchymal Transition Process].
    Zheng M; Huang Y; Fei W; Shen Y; Nie X; Gao MY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):342-349. PubMed ID: 36949696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A network map of cytoskeleton-associated protein 4 (CKAP4) mediated signaling pathway in cancer.
    Suchitha GP; Balaya RDA; Raju R; Keshava Prasad TS; Dagamajalu S
    J Cell Commun Signal; 2023 Sep; 17(3):1097-1104. PubMed ID: 36944905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of tumor-infiltrating immune cells in clinical early-stage oral squamous cell carcinoma.
    Huang Z; Lu Y; Wang W; Xie N; Yi C; Xiong G; Xu X; Zhang M; Wang C
    J Oral Pathol Med; 2023 May; 52(5):372-380. PubMed ID: 36135715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corneodesmosin as a potential target of oral squamous cell carcinoma.
    Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK
    Medicine (Baltimore); 2022 Sep; 101(39):e28397. PubMed ID: 36181011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CKAP4 is a Dickkopf1 receptor and is involved in tumor progression.
    Kimura H; Fumoto K; Shojima K; Nojima S; Osugi Y; Tomihara H; Eguchi H; Shintani Y; Endo H; Inoue M; Doki Y; Okumura M; Morii E; Kikuchi A
    J Clin Invest; 2016 Jul; 126(7):2689-705. PubMed ID: 27322059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.